During the past decade, National Koranyi Institute for TBC and Pulmonology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Koranyi Institute for TBC and Pulmonology" are "Cystic Fibrosis" (3 trials). Many other conditions were trialed in "National Koranyi Institute for TBC and Pulmonology" in a lesser frequency.

Most popular intervention types in "National Koranyi Institute for TBC and Pulmonology" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ELX/TEZ/IVA" (3 trials), "IVA" (3 trials), "Placebo (matched to ELX/TEZ/IVA)" (3 trials), "Placebo (matched to IVA)" (3 trials) and "Placebo (matched to VX-121/TEZ/D-IVA)" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Koranyi Institute for TBC and Pulmonology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "National Koranyi Institute for TBC and Pulmonology". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Koranyi Institute for TBC and Pulmonology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Koranyi Institute for TBC and Pulmonology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".